Stay updated on Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata. No other content changes are indicated.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThis update changes the displayed site revision from v3.5.2 to v3.5.3 for the study details page, reflecting a platform/version release rather than any modification to the trial’s content.SummaryDifference0.1%

- Check31 days agoChange DetectedAdded revision: v3.5.2; removed revision: v3.5.0.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. The change is limited to the page's version label and does not modify the study details or other content.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.